diarrhea on glp 1 GLP-1 Diarrhea: Causes, Treatment & Tips The best treatment is prevention.
Description
P., Daniels G
Labs are not routinely required unless clinically necessary

While most (79%) got their prescription from a primary care doctor or specialist, 11% used an online provider

Phase 2 Trial Design Participants: 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27), without diabetes Duration: 48 weeks Dosing groups: Placebo, 1mg, 4mg, 8mg, or 12mg weekly (with gradual dose escalation over 20-24 weeks) Primary endpoint: Percentage change in body weight from baseline Beyond Weight Loss: Metabolic Improvements Beyond weight loss, the 12mg dose also improved several cardiometabolic markers: Blood pressure: Systolic BP decreased by 7.4 mmHg (clinically significant reduction) Lipids: Triglycerides fell 30%, HDL cholesterol increased 8% Glucose control: HbA1c decreased 0.4% even in participants without diabetes Liver health: Markers of fatty liver disease (ALT, AST) improved significantly Inflammation: C-reactive protein (CRP) decreased, indicating reduced systemic inflammation What this means: Retatrutide appears to improve the metabolic dysfunction behind obesity-related diseases, not just the weight itself
Is Ozempic better for weight loss than other GLP-1 medications

Researchers also conducted an analysis using data from the WHOs pharmacovigilance database from April 28, 2005, to March 1, 2021
